BEVACIZUMAB and PYREXIA

Overview

PYREXIA is the #10 most commonly reported adverse reaction for BEVACIZUMAB, manufactured by Genentech, Inc.. There are 3,948 FDA adverse event reports linking BEVACIZUMAB to PYREXIA. This represents approximately 1.9% of all 204,762 adverse event reports for this drug.

Patients taking BEVACIZUMAB who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for BEVACIZUMAB, but still significant enough to appear in the safety profile.

Other Side Effects of BEVACIZUMAB

In addition to pyrexia, the following adverse reactions have been reported for BEVACIZUMAB:

• OFF LABEL USE — 13,542 reports
• DEATH — 12,987 reports
• DISEASE PROGRESSION — 7,200 reports
• DIARRHOEA — 7,113 reports
• NAUSEA — 6,315 reports
• FATIGUE — 6,126 reports
• HYPERTENSION — 5,689 reports
• VOMITING — 4,825 reports
• ANAEMIA — 4,274 reports
• NEUTROPENIA — 3,871 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does BEVACIZUMAB cause PYREXIA?

PYREXIA has been reported as an adverse event in 3,948 FDA reports for BEVACIZUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with BEVACIZUMAB?

PYREXIA accounts for approximately 1.9% of all adverse event reports for BEVACIZUMAB, making it a notable side effect.

What should I do if I experience PYREXIA while taking BEVACIZUMAB?

If you experience pyrexia while taking BEVACIZUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages